ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) Upgraded to “Hold” at Zacks Investment Research

Zacks Investment Research upgraded shares of ASPEN PHARMACAR/ADR (OTCMKTS:APNHY) from a sell rating to a hold rating in a research report released on Monday morning, Zacks.com reports.

According to Zacks, “Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. “

Separately, ValuEngine upgraded ASPEN PHARMACAR/ADR from a sell rating to a hold rating in a research note on Wednesday, October 2nd.

ASPEN PHARMACAR/ADR stock opened at $8.04 on Monday. The stock’s fifty day moving average price is $6.69 and its two-hundred day moving average price is $6.48. ASPEN PHARMACAR/ADR has a one year low of $4.14 and a one year high of $11.36.

About ASPEN PHARMACAR/ADR

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty, branded, and generic pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biogicals, active pharmaceutical ingredients, and infant nutritional products.

Further Reading: What are the advantages of the Stochastic Momentum Index?

Get a free copy of the Zacks research report on ASPEN PHARMACAR/ADR (APNHY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ASPEN PHARMACAR/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASPEN PHARMACAR/ADR and related companies with MarketBeat.com's FREE daily email newsletter.